Postdoctoral Position – CRISPR Modelling of TP53 Alterations in Leukemia

Overview

Postdoc in Uppsala's Department of Immunology, Genetics and Pathology building CRISPR-edited isogenic leukaemia cell lines to study how TP53 mutations change cell behaviour and drug response. Apply by 7 October 2026.

Eligibility

PhD in molecular biology, cell biology, cancer biology or related field, preferably completed within three years of the deadline; at least one first-author paper involving quantitative or image-based analysis.

Nationality: Open to all nationalities

Funding & Benefits

Two-year position (possible one-year extension) with fixed monthly pay.